Why the study?
Suspected endomyocardial fibrosis presents significant diagnostic and therapeutic challenges when characteristic imaging findings coexist with atypical features and definitive histological confirmation cannot be obtained.
Case Report (n=1)
No
This case highlights the diagnostic and therapeutic complexity of suspected endomyocardial fibrosis presenting in a non-endemic setting with biventricular dysfunction and an extensive LV thrombus when histological confirmation via endomyocardial biopsy cannot be safely obtained.
Answers are grounded in this paper and cite their sources.
May not respond to standard therapy in suspected EMF with large thrombus; leaves open optimal management without biopsy in non-endemic cases.
We report a case of a 64-year-old man with biventricular dysfunction and a large left ventricular (LV) thrombus in whom endomyocardial fibrosis (EMF) was suspected. Despite extensive evaluation for eosinophilic, autoimmune, infective, and haematological causes, no secondary aetiology was identified. He was managed with guideline-directed heart failure therapy and anticoagulation. His condition progressively deteriorated, and he died within a year, highlighting the diagnostic challenge of suspected EMF when characteristic imaging findings coexist with atypical features and definitive histological confirmation cannot be obtained, as well as the therapeutic challenges of this rare cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Geran et al. (2026) conducted a case report in Suspected endomyocardial fibrosis (EMF) with biventricular dysfunction and extensive left ventricular thrombus (n=1). Guideline-directed heart failure medical therapy (sacubitril/valsartan, bisoprolol, spironolactone, dapagliflozin) and warfarin anticoagulation was evaluated on Resolution of left ventricular thrombus, change in systolic function, and clinical survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: